Our study in leukemia models revealed that ABCB1 coding regions are stable even under stringent drug selection, thus suggesting that a mutant P-gp may not be a major factor responsible for the unsuccessful modulation of clinical MDR. The gene discussed is ABCB1; the disease is leukemia.